Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Analyst Ratings

Analyst Ratings

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Analyst Downgrades – Mplx (NYSE:MPLX) Stock Gets Downgraded By Barclays from Overweight to Equal Weight

ME Staff - January 17, 2018

Array Biopharma Inc (NASDAQ:ARRY) price target set to $22.00 by Cowen

argenx SE – ADR (NASDAQ:ARGX) had its Outperform ➝ Positive rating reiterated by Wedbush with a $121.00 price target

Analyst Activity – Morgan Stanley Lowers Its Price Target On Edison International (NYSE:EIX) to $71.00

Analyst Activity – Morgan Stanley Raises Its Price Target On Conduent (NYSE:CNDT) to $20.00

Analyst Activity – Canaccord Genuity Reiterates Buy on BJ’s Restaurants (NASDAQ:BJRI)

ME Staff - July 28, 2017 0

Fidelity National Information Servcs Inc (NYSE:FIS) price target raised to $370.00...

ME Staff - July 5, 2019 0

Analyst Upgrades – National Grid Transco, PLC (NYSE:NGG) Stock Gets Upgraded...

ME Staff - August 1, 2017 0

Analyst Activity – Jefferies Group Initiates Coverage On Cross Country Healthcare...

ME Staff - February 1, 2018 0

Analyst Activity – Credit Suisse Group Lowers Its Price Target On...

ME Staff - February 13, 2018 0

Analyst Activity – Barclays PLC Reiterates Hold on EnLink Midstream, LLC...

ME Staff - July 21, 2017 0

Analyst Activity – Royal Bank of Canada Reiterates Buy on NYSE:ESNT...

ME Staff - April 10, 2018 0

Analyst Activity – Deutsche Bank Lowers Its Price Target On NASDAQ:CASY...

ME Staff - June 13, 2018 0

Analyst Upgrades – NASDAQ:EGRX – Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Gets Upgraded...

ME Staff - June 11, 2018 0

Analyst Activity – B. Riley Initiates Coverage On Achillion Pharmaceuticals (NASDAQ:ACHN)...

ME Staff - February 8, 2018 0
123...2,175Page 1 of 2,175

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 6, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 15, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019